Managing Director and co-owner of Iperion, Frits Stulp, wrote an article that was published by Pharmaceutical Executive. In this article he reminds companies about the importance of ISO IDMP and the ultimate end goal: Patient Safety
Product data, not just for regulators
International regulators’ hunger for increasingly detailed product information and complete lifecycle traceability might be the primary driver for new systems and process investment. Yet it is ultimately the public’s expectations that should dictate the need to build comprehensive, updated status information which patients, clinicians and pharmacists can call up on demand. Frits Stulp takes a fresh look at the latest life sciences transparency initiatives in this context, and provides his perspective on what firms should do next.